Visuospatial working memory is impaired in an animal model of schizophrenia induced by acute MK-801: An effect of pretraining

Pharmacology Biochemistry and Behavior

Volumn 106, Issue , 2013, Pages 117-123

  Zemanova, Anna ^a   Stankova, Anna ^a   Lobellova, Veronika ^a   Svoboda, Jan ^a   Vales, Karel ^a   Vlcek, Kamil ^a   Kubik, Stepan ^a   Fajnerova, Iveta ^a   Stuchlik, Ales ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Allothetic place avoidance alternation; Dizocilpine; Navigation; Schizophrenia; Working memory

Indexed keywords

DIZOCILPINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; LOCOMOTION; MALE; MEMORY DISORDER; NONHUMAN; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; TASK PERFORMANCE; VISUOSPATIAL WORKING MEMORY IMPAIRMENT;

ANIMALS; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; MALE; RATS; RATS, LONG-EVANS; SCHIZOPHRENIA;

EID: 84878218888     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2013.03.014     Document Type: Article

References (42)

1. L.C. Amann, M.J. Gandal, T.B. Halene, R.S. Ehrlichman, S.L. White, and H.S. McCarren Mouse behavioral endophenotypes for schizophrenia Brain Res Bull 83 2010 147 161
2. D.M. Barch, and A. Ceaser Cognition in schizophrenia: core psychological and neural mechanisms Trends Cogn Sci 16 2012 27 34
3. D.M. Barch, and E. Smith The cognitive neuroscience of working memory: relevance to CNTRICS and schizophrenia Biol Psychiatry 64 2008 11 17
4. J.W. Brown, C.A. Whitehead, A.M. Basso, L.E. Rueter, and M. Zhang Preclinical evaluation of non-imidazole histamine H3 receptor antagonists in comparison to atypical antipsychotics for the treatment of cognitive deficits associated with schizophrenia Int J Neuropsychopharmacol 21 2012 1 16
5. V. Bubenikova-Valesova, A. Stuchlik, J. Svoboda, J. Bures, and K. Vales Risperidone and ritanserin but not haloperidol block effect of dizocilpine on the active allothetic place avoidance task Proc Natl Acad Sci U S A 105 2008 1061 1066 (Pubitemid 351282081)
6. J. Bures, A.A. Fenton, Y. Kaminsky, and L. Zinyuk Place cells and place navigation Proc Natl Acad Sci U S A 94 1997 343 350 (Pubitemid 27027212)
7. E.R. Butelman A novel NMDA antagonist, MK-801, impairs performance in a hippocampal-dependent spatial learning task Pharmacol Biochem Behav 34 1989 13 16 (Pubitemid 20008876)
8. Z. Caramanos, and M.L. Shapiro Spatial memory and N-methyl-D-aspartate receptor antagonists APV and MK-801: memory impairments depend on familiarity with the environment, drug dose, and training duration Behav Neurosci 108 1994 30 43 (Pubitemid 24097742)
9. S.A. Castner, P.S. Goldman-Rakic, and G.V. Williams Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia Psychopharmacology (Berl) 174 2004 111 125 (Pubitemid 38925096)
10. C.A. Dockery, and M.J. Wesierska A spatial paradigm, the allothetic place avoidance alternation task, for testing visuospatial working memory and skill learning in rats J Neurosci Methods 191 2010 215 221
11. C.A. Dockery, D. Liebetanz, N. Birbaumer, M. Malinowska, and M.J. Wesierska Cumulative benefits of frontal transcranial direct current stimulation on visuospatial working memory training and skill learning in rats Neurobiol Learn Mem 96 2011 452 460
12. P.A. Dudchenko An overview of the tasks used to test working memory in rodents Neurosci Biobehav Rev 28 2004 699 709 (Pubitemid 39535867)
13. P.A. Dudchenko, J. Talpos, J. Young, and M.G. Baxter Animal models of working memory: A review of tasks that might be used in screening drug treatments for the memory impairments found in schizophrenia Neurosci Biobehav Rev 2013 (in press)
14. A. Egerton, and J.M. Stone The glutamate hypothesis of schizophrenia: neuroimaging and drug development Curr Pharm Biotechnol 13 2012 1500 1512
15. B.A. Ellenbroek, and A.R. Cools Animal models with construct validity for schizophrenia Behav Pharmacol 1 1990 469 490
16. P. Fadda, L. Robinson, W. Fratta, R.G. Pertwee, and G. Riedel Scopolamine and MK801-induced working memory deficits in rats are not reversed by CBD-rich cannabis extracts Behav Brain Res 168 2006 307 311 (Pubitemid 43201948)
17. J. Kantrowitz, and D.C. Javitt Glutamatergic transmission in schizophrenia: from basic research to clinical practice Curr Opin Psychiatry 25 2012 96 102
18. R. Kerwin, S. Patel, and B. Meldrum Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem Neuroscience 39 1990 25 32
19. V. Lobellova, M. Entlerova, B. Svojanovska, H. Hatalova, I. Prokopova, T. Petrasek, K. Vales, S. Kubik, I. Fajnerova, and A. Stuchlik Two learning tasks provide evidence for disrupted behavioural flexibility in an animal model of schizophrenia-like behaviour induced by acute MK-801: A dose-response study Behav Brain Res. 246 2013 55 62
20. J.W. Newcomer, and J.H. Krystal NMDA receptor regulation of memory and behavior in humans Hippocampus 11 2001 529 542 (Pubitemid 33100374)
21. M. Nilsson, S. Waters, N. Waters, A. Carlsson, and M.L. Carlsson A behavioural pattern analysis of hypoglutamatergic mice - effects of four different antipsychotic agents J Neural Transm 108 2001 1181 1196 (Pubitemid 33022768)
22. M. Nilsson, A. Carlsson, K.R. Markinhuhta, C. Sonesson, F. Pettersson, and M. Gullme The dopaminergic stabiliser ACR16 counteracts the behavioural primitivization induced by the NMDA receptor antagonist MK-801 in mice: implications for cognition Prog Neuropsychopharmacol Biol Psychiatry 28 2004 677 685 (Pubitemid 38987392)
23. C.M. O'Carroll, S.J. Martin, J. Sandin, B. Frenguelli, and R.G. Morris Dopaminergic modulation of the persistence of one-trial hippocampus-dependent memory Learn Mem 13 2006 760 769 (Pubitemid 44871677)
24. M. Pitkänen, J. Sirviö, E. MacDonald, S. Niemi, T. Ekonsalo, and P. Riekkinen Sr. The effects of D-cycloserine and MK-801 on the performance of rats in two spatial learning and memory tasks Eur Neuropsychopharmacol 5 1995 457 463 (Pubitemid 3008631)
25. I. Prokopova, S. Bahnik, V. Doulames, K. Vales, T. Petrasek, and J. Svoboda Synergistic effects of dopamine D2-like receptor antagonist sulpiride and beta-blocker propranolol on learning in the Carousel maze, a dry-land spatial navigation task Pharmacol Biochem Behav 102 2012 151 156
26. P.J. Quee, P.A. Eling, F.M. van der Heijden, and H. Hildebrandt Working memory in schizophrenia: a systematic study of specific modalities and processes Psychiatry Res 185 2011 54 59
27. J.P. Rung, A. Carlsson, K. Rydén Markinhuhta, and M.L. Carlsson (+)-MK-801 induced social withdrawal in rats; a model for negative symptoms of schizophrenia Prog Neuropsychopharmacol Biol Psychiatry 29 2005 827 832 (Pubitemid 40897800)
28. D. Saucier, E.L. Hargreaves, F. Boon, C.H. Vanderwolf, and D.P. Cain Detailed behavioral analysis of water maze acquisition under systemic NMDA or muscarinic antagonism: nonspatial pretraining eliminates spatial learning deficits Behav Neurosci 110 1996 103 116 (Pubitemid 26068799)
29. M.L. Shapiro, and C. O'Connor N-methyl-D-aspartate receptor antagonist MK-801 and spatial memory representation: working memory is impaired in an unfamiliar environment but not in a familiar environment Behav Neurosci 106 1992 604 612
30. R.J. Steele, and R.G. Morris Delay-dependent impairment of a matching-to-place task with chronic and intrahippocampal infusion of the NMDA-antagonist D-AP5 Hippocampus 9 1999 118 136 (Pubitemid 29196956)
31. A. Stuchlík, and K. Vales Systemic administration of MK-801, a non-competitive NMDA-receptor antagonist, elicits a behavioural deficit of rats in the Active Allothetic Place Avoidance (AAPA) task irrespectively of their intact spatial pretraining Behav Brain Res 159 1 2005 163 171 (Pubitemid 40410598)
32. A. Stuchlik, L. Rezacova, K. Vales, V. Bubenikova, and S. Kubik Application of a novel Active Allothetic Place Avoidance task (AAPA) in testing a pharmacological model of psychosis in rats: comparison with the Morris Water Maze Neurosci Lett 366 2004 162 166 (Pubitemid 38970148)
33. A. Stuchlik, T. Petrasek, and K. Vales Dopamine D2 receptors and alpha1-adrenoceptors synergistically modulate locomotion and behavior of rats in a place avoidance task Behav Brain Res 189 2008 139 144
34. A. Stuchlik, T. Petrasek, H. Hatalová, L. Rambousek, T. Nekovarova, and K. Vales Behavioral tests for evaluation of information processing and cognitive deficits in rodent animal models of neuropsychiatric disorders, schizophrenia in the 21st century T.H.J. Burne, 2012 InTech Rijeka, Croatia 978-953-51-0315-8
35. K. Vales, and A. Stuchlik Central muscarinic blockade interferes with retrieval and reacquisition of active allothetic place avoidance despite spatial pretraining Behav Brain Res 161 2005 238 244 (Pubitemid 40732406)
36. K. Vales, V. Bubenikova-Valesova, D. Klement, and A. Stuchlik Analysis of sensitivity to MK-801 treatment in a novel active allothetic place avoidance task and in the working memory version of the Morris water maze reveals differences between Long-Evans and Wistar rats Neurosci Res 55 4 2006 383 388 (Pubitemid 43866248)
37. K. Vales, J. Svoboda, K. Benkovicova, V. Bubenikova-Valesova, and A. Stuchlik The difference in effect of mGlu2/3 and mGlu5 receptor agonists on cognitive impairment induced by MK-801 Eur J Pharmacol 639 2010 91 98
38. F.J. van der Staay, K. Rutten, C. Erb, and A. Blokland Effects of the cognition impairer MK-801 on learning and memory in mice and rats Behav Brain Res 220 2011 215 229
39. J. van Os, and S. Kapur Schizophrenia Lancet 374 2009 635 645
40. M. Wesierska, C. Dockery, and A.A. Fenton Beyond memory, navigation, and inhibition: behavioral evidence for hippocampus-dependent cognitive coordination in the rat J Neurosci 25 2005 2413 2419 (Pubitemid 40322283)
41. A.M. White, and P.J. Best The effects of MK-801 on spatial working memory and within-session spatial learning Pharmacol Biochem Behav 59 1998 613 617 (Pubitemid 28144200)
42. D.F. Wozniak, J.W. Olney, L. Kettinger III, M. Price, and J.P. Miller Behavioral effects of MK-801 in the rat Psychopharmacology (Berl) 101 1990 47 56 (Pubitemid 20124741)